European Association of Urology (EAU) guidelines: do we care? Reflections from the EAU Impact Assessment of Guidelines Implementation and Education group

Alberto Briganti, Steven MacLennan, Lorenzo Marconi, Karin Plass, James N'Dow, EAU Guidelines Office ‘IMAGINE’ project

Research output: Contribution to journalEditorial

187 Citations (Scopus)

Abstract

There is increasing evidence in the literature that androgen deprivation therapy (ADT) is overused among practising urologists in the setting of localized, and even locally advanced, prostate cancer (PCa). Morgia et al. report a misuse of ADT prescriptions among Italian urologists in roughly a quarter of cases, mainly in the setting of low-risk/localized disease where ADT may harm patients without proven benefit with regard to disease-specific outcomes. Such clinical practice behaviours are even more unjustifiable given the high level of evidence upon which the current European Association of Urology (EAU) guidelines recommendations on ADT use are based.
Original languageEnglish
Pages (from-to)850-851
Number of pages2
JournalBJU International
Volume117
Issue number6
Early online date13 May 2016
DOIs
Publication statusPublished - Jun 2016

Fingerprint Dive into the research topics of 'European Association of Urology (EAU) guidelines: do we care? Reflections from the EAU Impact Assessment of Guidelines Implementation and Education group'. Together they form a unique fingerprint.

  • Cite this